A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes.

Tcheng, J E

A symposium: safety issues concerning the use of glycoprotein IIb-IIIa inhibitors in the management of acute coronary syndromes. [electronic resource] - American heart journal Oct 1999 - 261-2 p. digital

Publication Type: Journal Article

0002-8703

10.1053/hj.1999.v138.a100464 doi


Abciximab
Acute Disease
Angina, Unstable--drug therapy
Antibodies, Monoclonal--therapeutic use
Anticoagulants--therapeutic use
Coronary Disease--drug therapy
Eptifibatide
Humans
Immunoglobulin Fab Fragments--therapeutic use
Myocardial Infarction--drug therapy
Myocardial Ischemia--drug therapy
Peptides--therapeutic use
Platelet Aggregation Inhibitors--therapeutic use
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Safety
Tirofiban
Tyrosine--analogs & derivatives